International Emerging Markets — Revenues:
Pfizer International Emerging Markets — Revenues: increased by 6.0% to $2.29B in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests successful market penetration and rising demand for the company's products in developing economies, while a decrease may indicate regulatory hurdles, currency volatility, or increased local competition.
Detailed definition
This metric represents the total revenue generated from pharmaceutical product sales within geographic regions classifie...
Peer comparison
Peers in the pharmaceutical industry typically report this as part of their 'Rest of World' or 'Emerging Markets' geographic segment, often benchmarked against regional GDP growth and local healthcare spending trends.
pfe_segment_international_emerging_markets_revenuesHistorical Data
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $2.16B | $2.29B |
| QoQ Change | — | +6.0% |
| YoY Change | — | +6.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Pfizer's international emerging markets — revenues:?
- Pfizer (PFE) reported international emerging markets — revenues: of $2.29B in Q1 2026.
- What does international emerging markets — revenues: mean?
- Total revenue earned from pharmaceutical sales in developing international markets.